Multiparametric MRI accurately detects prostate cancer

This article originally appeared here.
Multiparametric MRI accurately detects prostate cancer
Multiparametric MRI accurately detects prostate cancer

(HealthDay News) -- Multiparametric magnetic resonance imaging is highly accurate for the detection of prostate cancer in patients with clinically low-risk cancer, particularly for cancers with larger volume and higher Gleason grade, according to a study published in the May issue of Radiology.

Jin Young Kim, M.D., from Keimyung University in Daegu, South Korea, and colleagues examined 100 patients with clinically determined low-risk prostate cancer utilizing multiparametric magnetic resonance imaging (T2 weighted, diffusion weighted, and dynamic contrast material enhanced) before prostatectomy. The images were compared to histopathologic examination.

The researchers found that multiparametric magnetic resonance imaging showed high diagnostic performance for the detection of cancer ≥0.5 cm³ with respect to cancer volume and Gleason grade. This diagnostic accuracy was significantly higher for cancers with a volume >1 cm³, compared those with a volume of 0.5 to 1 cm³ (87.7 versus 82.6 percent; P = 0.02) and for cancers with Gleason grades of ≥7 versus grades ≤6 (89.2 versus 80.6 percent; P = 0.01).

"Detection of prostate cancer in patients with clinically low-risk cancer with multiparametric magnetic resonance imaging is highly accurate, and larger cancer volume and higher Gleason grade are associated with higher detection accuracy," the authors write.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs